Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P), and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP) - Noreddin,A.M.; Marras,T.K.; Sanders,K.; Chan,C.KN.; Hoban,D.J.; Zhanel,G.G. (Int J Antimicrob Agents, 2004)